Author:
Neda Naseri Azar,Alireza Habibi,Reza Kazemi Darsanaki
Publisher
Springer Science and Business Media LLC
Reference47 articles.
1. Testa, U., Castelli, G., & Pelosi, E. (2018). Lung cancers: Molecular characterization, clonal heterogeneity and evolution, and cancer stem cells. Cancers, 10(8)), 248. https://doi.org/10.3390/cancers10080248
2. Perlikos, F., Harrington, K. J., & Syrigos, K. N. (2013). Key molecular mechanisms in lung cancer invasion and metastasis: A comprehensive review. Critical reviews in oncology/hematology, 87(1), 1–11. https://doi.org/10.1016/j.critrevonc.2012.12.007
3. Ali, Z., Jabir, M., & Al-Shammari, A. (2019). Gold nanoparticles inhibiting proliferation of Human breast cancer cell line. Research journal of biotechnology, 14, 79–82.
4. Tartarone, A., Giordano, P., Lerose, R., Rodriquenz, M. G., Conca, R., & Aieta, M. (2017). Progress and challenges in the treatment of small cell lung cancer. Medical oncology., 34(6), 110. https://doi.org/10.1007/s12032-017-0966-6
5. Aalders, K. C., Tryfonidis, K., Senkus, E., & Cardoso, F. (2017). Anti-angiogenic treatment in breast cancer: Facts, successes, failures and future perspectives. Cancer treatment reviews, 53, 98–110. https://doi.org/10.1016/j.ctrv.2016.12.009